Article date: 1992/3/1
PubMed ID: 1354334
Journal name: Neuroendocrinology (ISSN: 0028-3835)
The effects of GABAergic influences intrinsic to the hypothalamus on the secretion of somatostatin were studied using cultured fetal rat hypothalamic neurons. The existence of GABAergic neurons within the cultures was confirmed by immunocytochemistry. These neurons appeared to be actively secreting GABA as antagonism of GABAA receptors with bicuculline and picrotoxinin caused a dose-dependent increase in the release of immunoreactive somatostatin (SRIF), which was Ca(2+)-dependent. Although exogenous GABA inhibited SRIF secretion at concentrations of 10(-6) M and greater, muscimol, a GABAA agonist, inhibited SRIF release at 10(-8) M, whereas baclofen, a GABAB agonist, required concentrations two orders of magnitude greater to produce an effect. Phaclofen, a GABAB antagonist, was inactive (10(-8)-10(-4) M). A GABA uptake inhibitor, SKF 89976A, produced a dose-dependent inhibition of SRIF release. These results, therefore, support a role for intrahypothalamic GABA neurons in the regulation of SRIF secretion in the neonatal rat, predominantly via a type A receptor, and provide further evidence for a neuroendocrine role for GABA in controlling growth hormone secretion.
Author List: Gillies G, Davidson K
Publication Types: Journal Article; Research Support, Non-U.S. Gov't
Substances mentioned in the article: Culture Media; GABA Antagonists; Nipecotic Acids; Receptors, GABA-A; Muscimol; Somatostatin; gamma-Aminobutyric Acid; N-(4,4-diphenyl-3-butenyl)nipecotic acid; Baclofen; Bicuculline;
Mesh terms: Animals; Baclofen/pharmacology; Bicuculline/pharmacology; Cells, Cultured; Culture Media; GABA Antagonists; Hypothalamus/drug effects; Muscimol/pharmacology; Neurons/metabolism; Nipecotic Acids/pharmacology; Rats; Receptors, GABA-A/physiology; Somatostatin/secretion; gamma-Aminobutyric Acid/pharmacology;